Prospective analysis of liquid biopsies of advanced non-small cell lung cancer patients after progression to targeted therapies using GeneReader NGS platform
Author(s) -
Clara Mayo de las Casas,
Mónica GarzónIbáñez,
Núria JordanaAriza,
Santiago Viteri,
Irene MoyaHorno,
Niki Karachaliou,
Zaira Yeste,
Raquel Munhoz da Silveira Campos,
Sergi Villatoro,
Ariadna BaladaBel,
Beatriz GarcíaPeláez,
Noemı́ Reguart,
Cristina Teixidó,
Eloísa JantusLewintre,
Sílvia Calabuig-Fariñas,
Cristina Aguado,
Ana GiménezCapitán,
Ruth Román-Lladó,
Ana Pérez-Rosado,
María José Catalán,
Jordi BertranAlamillo,
Silvia García-Román,
Sónia Rodríguez,
Lidia Alonso,
Erika Aldeguer,
Alejandro MartínezBueno,
María GonzálezCao,
A. Aguilar Hernandez,
Juan Garcia,
María de los Llanos Gil,
Manuel DelgadoFernández,
Rafael Rosell,
Miguel Ángel MolinaVila
Publication year - 2018
Publication title -
translational cancer research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.254
H-Index - 30
eISSN - 2219-6803
pISSN - 2218-676X
DOI - 10.21037/tcr.2018.10.12
Subject(s) - kras , liquid biopsy , lung cancer , medicine , osimertinib , t790m , oncology , biopsy , cancer , prospective cohort study , targeted therapy , immunotherapy , pathology , cancer research , colorectal cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom